Cuban COVID vaccine Abdala 92 percent 'effective', maker says

Cuba's Abdala coronavirus candidate vaccine showed "efficacy" of more than 92 percent after three doses, its maker said Monday, though it did not specify whether this was measured against infection, disease, or death.